A certain protein builds up in the brains of most Parkinson's patients, a study confirmed on Thursday using a new technique hailed as a potential "game-changer" that could point towards a way to test for the debilitating ...
Apr 15, 2023
0
64
The Lancet Neurology has published data from the phase 3 MycarinG study evaluating the efficacy and safety of rozanolixizumab in adult patients with acetylcholine receptor autoantibody-positive (AChR-Ab+) or muscle-specific ...
Apr 13, 2023
0
21
A technique that identifies the build-up of abnormal protein deposits linked to Parkinson's disease could aid in early detection and play a key role in the disease's clinical diagnosis and characterization, according to research ...
Apr 12, 2023
0
97
In the current edition of The Lancet Neurology, researchers of the Human Brain Project (HBP) present the novel clinical uses of advanced brain modeling methods. Computational brain modeling techniques that integrate the ...
Mar 27, 2023
0
128
Together with multiple sclerosis (MS) experts, biostatisticians and clinicians from across the globe, a UK HealthCare neurologist has helped compile an essential list of MS medications for patients in resource-poor settings.
Mar 2, 2023
0
12
An international panel led by a pediatric neuroimmune expert and co-director of the Neuroscience Center at Children's Hospital of Philadelphia (CHOP) has established new criteria for properly diagnosing myelin oligodendrocyte ...
Feb 16, 2023
0
19
US pharmaceutical giant Pfizer has obtained positive results in late-stage testing for a nasal spray designed to treat migraines, a study showed Thursday.
Feb 16, 2023
0
19
The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective ...
Jan 20, 2023
0
65
A universal criteria for diagnosing the blinding eye condition optic neuritis has been developed by a UCL-led team of researchers.
Jan 12, 2023
0
4
Amyloid plaques—protein clumps that are one of the hallmarks of Alzheimer's disease—occur at roughly the same level in the brains of people with Down syndrome who have Alzheimer's as they do in people with forms of hereditary, ...
Dec 13, 2022
0
45
